# PALATIN TECHNOLOGIES INC: Form D filing

PALATIN TECHNOLOGIES INC, a pharmaceuticals company in Cranbury, NJ, filed a Form D with the SEC in 2012. The latest, on July 13, 2012, reports $35 million sold of a $35 million offering to 3 investors.

Find out what PALATIN TECHNOLOGIES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PALATIN%20TECHNOLOGIES%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PALATIN%20TECHNOLOGIES%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fpalatin-technologies-inc-911216)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PALATIN%20TECHNOLOGIES%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PALATIN%20TECHNOLOGIES%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fpalatin-technologies-inc-911216)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4B CEDAR BROOK DRIVE, Cranbury, NJ, 08512
- Phone: (609) 495-2200
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $1,000,001 - $5,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 911216

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 13, 2012 | New notice | $35,000,000 | $35,000,000 | $0 | 3 | Jul 2, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/911216/000091121612000002/0000911216-12-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Zola P. Horovitz | Director |  |
| Robert I. Taber | Director |  |
| Robert K. deVeer | Director |  |
| John K. A. Prendergast | Director |  |
| Stephen T. Wills | Executive Officer |  |
| Perry B. Molinoff | Director |  |
| Alan W. Dunton | Director |  |
| Joseph Stanley Hull | Director |  |
| Carl Spana | Executive Officer, Director |  |

## Other pharmaceuticals companies in New Jersey that filed recently

- [Grace Therapeutics, Inc.](https://specstream.ai/data/form-d/company/grace-therapeutics-inc-1444192) $10 million · Aug 11, 2026

[Every Form D from the week of Jul 9, 2012](https://specstream.ai/data/form-d/week/2012-07-09) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what PALATIN TECHNOLOGIES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).